Clinical Trial Update: A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma. [Phase 1]

View source ↗

Summary

A Phase 1 single ascending dose study of R1671 in patients with mild intermittent asymptomatic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• R1671

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 1 | Status: COMPLETED